Suchergebnisse - "Germain, Guillaume"

PubPharm (99)

1

Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures : RAPID3, swollen joint count and tender joint count

enthalten in: Lupus science & medicine | 2024

von Germain, G. | Worley, K. | MacKnight, S. | +6

2

Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma

enthalten in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology | 2024

von Casale, T. | Corbridge, T. | Germain, G. | +5

3

Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma

enthalten in: Allergy, asthma and clinical immunology | 2024

von Casale, T. | Corbridge, T. | Germain, G. | +5

4

Real-world users of triple therapy for asthma in the US

enthalten in: The American journal of managed care | 2024

von Hansel, N. | Abbott, C. | Averell, C. | +5

5

Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Jain, R. | Laliberté, F. | Germain, G. | +4

6

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1 : The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

enthalten in: Infectious diseases and therapy | 2023

von Priest, J. | Germain, G. | Laliberté, F. | +4

7

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

enthalten in: Infectious diseases and therapy | 2023

von Priest, J. | Germain, G. | Laliberté, F. | +4

8

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

enthalten in: Infectious diseases and therapy | 2023

von Priest, J. | Germain, G. | Laliberté, F. | +4

9

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

enthalten in: Infectious diseases and therapy | 2023

von Priest, J. | Germain, G. | Laliberté, F. | +4

10

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

enthalten in: Advances in therapy | 2023

von Berger, J. | Ashton, V. | Laliberté, F. | +6

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]